{"id":"NCT00770133","sponsor":"Bausch & Lomb Incorporated","briefTitle":"Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis.","officialTitle":"A Multi-center, Double-masked, Randomized, Placebo-controlled Evaluation of the Onset and Duration of Action of KetoNaph Ophthalmic Solution in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-02","primaryCompletion":"2010-04","completion":"2010-06","firstPosted":"2008-10-09","resultsPosted":"2020-10-27","lastUpdate":"2020-10-27"},"enrollment":141,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Allergic Conjunctivitis"],"interventions":[{"type":"DRUG","name":"Ketotifen/naphazoline","otherNames":[]},{"type":"DRUG","name":"Naphazoline","otherNames":[]},{"type":"DRUG","name":"Ketotifen","otherNames":[]},{"type":"DRUG","name":"Vehicle","otherNames":[]}],"arms":[{"label":"Ketotifen/naphazoline","type":"EXPERIMENTAL"},{"label":"Vehicle","type":"PLACEBO_COMPARATOR"},{"label":"Naphazoline","type":"ACTIVE_COMPARATOR"},{"label":"Ketotifen","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to establish the safety and efficacy of ketotifen/naphazoline ophthalmic solution compared to vehicle and its individual components in alleviating the signs and symptoms of conjunctival allergen challenge (CAC)-induced allergic conjunctivitis.","primaryOutcome":{"measure":"Ocular Itching","timeFrame":"3, 5, and 7 minutes post challenge at 14 days","effectByArm":[{"arm":"Ketotifen/Naphazoline","deltaMin":0.43,"sd":0.62},{"arm":"Ketotifen","deltaMin":0.4,"sd":0.65},{"arm":"Naphazoline","deltaMin":1.6,"sd":0.92},{"arm":"Vehicle","deltaMin":1.81,"sd":0.88}],"pValues":[]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":35},"commonTop":[]}}